Oct 24, 2025
Patients, and market forces, should be the ones to decide whether a community needs new healthcare facilities.
Oct 15, 2025
If premiums rise next year, it will be because Democrats effectively outlawed affordable coverage 15 years ago with Obamacare.
Oct 9, 2025
A number of unscrupulous companies have sought to capitalize on the growing demand for GLP-1s in ways putting patients at serious risk. Many telehealth services and online pharmacies, are making their own unapproved versions of these medicines.
Oct 3, 2025
American patients have shouldered a disproportionate share of the globe's research and development tab.
Sep 25, 2025
Unless our own government changes course, we'll suffer the same fate as Britain. Signs of drug companies losing patience with Britain's price controls have been apparent for years. The British government has ensured that drug firms have fewer resources for medicines.
Sep 16, 2025
Eliminating regulations that make it difficult to build factories and gain regulatory approval for new drug-manufacturing facilities would be far more effective at convincing pharmaceutical companies to set up shop here.
Sep 4, 2025
The Biden administration made exchange premium subsidies even more generous than the Affordable Care Act. The 2022 Inflation Reduction Act extended those enhanced subsidies. Anyone earning between 100% and 150% of the federal poverty level has access to zero-cost insurance.
Aug 29, 2025
The choice before the Trump administration is whether to move forward with drug price controls that will sap the pharmaceutical sector of resources, energy, and ingenuity -- or whether it will work to build a freer market for prescription drugs.